Several genes strongly related to pyruvate metabolism, glycolysis/gluconeogenesis, and tyrosine metabolism, including ACSS2, were found to be significantly downregulated in PGG-treated MDA-MB-231 breast cancer cells. This evidence concerns the gene ACSS2 and breast cancer.